Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1224 Results

Title
Intervention Indication Therapeutic Area Year Actions
Diclofenac-clotrimazole for treating recurrent vulvovaginal candidiasis Diclofenac-clotrimazole Vulvovaginal candidiasis Gynaecology and Obstetrics , Infectious Disease 2024 View  |  Download
Dexmedetomidine film for agitation in schizophrenia Dexmedetomidine Schizophrenia Mental and Behavioural Health 2022 View  |  Download
Dexmedetomidine film for agitation associated with bipolar disorder Dexmedetomidine Bipolar disorder Mental and Behavioural Health 2022 View  |  Download
Deucravacitinib for treating active psoriatic arthritis Deucravacitinib (BMS-986165) Psoriatic arthritis Dermatology , Rheumatology 2023 View  |  Download
Dersimelagon for previously untreated erythropoietic protoporphyria and X-linked protoporphyria Dersimelagon Erythropoietic protoporphyria , X-linked protoporphyria Dermatology , Haematology 2022 View  |  Download
DermaSys for erectile dysfunction Glyceryl Trinitrate (MED2002; MED2005; Eroxon; DermaSys) Erectile dysfunction Men's Health 2020 View  |  Download
Depemokimab for treating chronic rhinosinusitis withnasal polyps Depemokimab Nasal polyps , Rhinosinusitis Ear Nose and Throat (ENT) 2024 View  |  Download
Depemokimab as adjunctive therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and older Depemokimab Asthma Respiratory System 2024 View  |  Download
Depatuxizumab mafodotin for newly diagnosed EGFR‐amplified glioblastoma – first line Depatuxizumab mafodotin (ABT-414) , Temozolomide (Temodar; Temodal; SCH 52365) Glioma Neurological Cancer 2018 View  |  Download
Denosumab for the prevention of skeletal related events in patients with multiple myeloma – first line Denosumab (AMG 162; Prolia; Xgeva) Prevention of skeletal related events in multiple myeloma Haematological Cancer and Lymphomas , Musculoskeletal System 2017 View  |  Download
1 2 91 92 93 94 95 122 123
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications